title: Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment.
abstract: OBJECTIVE
  To examine the effectiveness of a 6-month treatment consisting of a weekly oral dose of 150 mg fluconazole for women with vestibulitis, and to explore the causes of treatment failure.
  
  
  METHODS
  Forty women with vestibulitis were randomized to either of two treatment groups. One group received a 6-month low oxalate diet with calcium citrate complement, as a placebo, and the second group the same diet and calcium citrate with the addition of a weekly oral tablet of 150 mg fluconazole. The women were examined 3 months after completing treatment, for response to therapy.
  
  
  RESULTS
  The addition of intensive 6-month fluconazole treatment did not lead to an outcome better than that attained by maintaining a low oxalate diet with calcium citrate supplementation. The satisfactory response rate was 15 and 30%, respectively. The presence of 'complicated vestibulitis', candidiasis concomitant with vestibulitis, decreases the satisfactory response rate regardless of the type of treatment administered (odds ratio 19.9, 95% CI 1.6, 250).
  
  
  CONCLUSIONS
  Prolonged oral fluconazole is an ineffective treatment of vestibulitis, whether pure or complicated by concomitant vulvovaginal candidiasis. The coexistence of candidiasis and vestibulitis - complicated vestibulitis - might represent a subset of vestibulitis that is resistant to the currently available medical therapy.
authors.affiliation: Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel. mdjacob@tx.technion.ac.il
authors.forename: J
authors.initials: J
authors.lastname: Bornstein
authors.forename: G
authors.initials: G
authors.lastname: Livnat
authors.forename: Z
authors.initials: Z
authors.lastname: Stolar
authors.forename: H
authors.initials: H
authors.lastname: Abramovici
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000150:complications / Q000188:drug therapy; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation; D014845:Vulvar Diseases / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole